Moreover, we found that the C‐MET/STAT3 signaling axis acted as a novel downstream target of PLAGL2 and contributed to the inhibition of PLAGL2‐mediated proliferation and apoptosis induction of SeS2 in HCC in vitro and in vivo. This evidence concerns the gene PLAGL2 and hepatocellular carcinoma.